Use of SV40 to immunize against hepatitis B surface antigen: Implications for the use of SV40 for gene transduction and its use as an immunizing agent

Gene Therapy

Volumn 5, Issue 5, 1998, Pages 575-582

  Kondo, R ^a   Feitelson, M A ^a   Strayer, D S ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Gene transfer; Papovavirus; Transgene expression

Indexed keywords

COMPLEMENTARY DNA; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS T ANTIGEN; VIRUS VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE TRANSFER; GENETIC TRANSDUCTION; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

ANIMALIA; HEPATITIS B VIRUS; PAPOVAVIRIDAE; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0031834248     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300623     Document Type: Article

References (48)

1. Strayer DS. Novel vectors for gene therapy. Adv Drug Deliv Rev 1995; 17: 235-238.
2. Strayer DS. SV40 as an effective gene transfer vector in vivo. J Biol Chem 1996; 271: 24741-24746.
3. Strayer DS, Milano J. SV40 mediates stable gene transfer in vivo. Gene Therapy 1996; 3: 581-587.
4. Chia W, Rigby PW. Fate of viral DNA in nonpermissive cells infected with simian virus 40. Proc Natl Acad Sci USA 1981; 78: 6638-6642.
5. Strayer DS, Kondo R, Milano J, Duan L-X. Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Therapy 1997; 4: 219-225.
6. Yoffe B, Noonan CA. Hepatitis B virus: new and evolving issues. Dig Dis Sci 1992; 37: 1-9.
7. Buendia MA. Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res 1992; 59: 167-226.
8. Beasley RP. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-1956.
9. Ellis RW, Kniskem DJ. Recombinant hepatitis B vaccines. In: McLachlan A (ed). Molecular Biology of the Hepatitis B Virus. CRC Press: Boca Raton, FL, 1991, pp 307-322.
10. Heermann K-H et al. Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 1984; 52: 396-402.
11. Kruskall MS et al. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992; 175: 495-502.
12. Mackett M, Yilma T, Rose JK, Moss B. Vaccinia virus recombinants; expression of VSV genes and protective immunization of mice and cattle. Science 1985; 227: 433-435.
13. Davis AR et al Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc Natl Acad Sci USA 1985; 82: 7560-7564.
14. Blancou J et al. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 1986; 322: 373-375.
15. Wiktor TJ et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 1984; 81: 7194-7198.
16. Brochier B et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 1991; 354: 520-522.
17. Boursnell ME et al. A recombinant fowlpox virus expressing the (NDV) protects chickens against challenge by NDV. Virology 1990; 178: 297-300.
18. Bayliss CD et al. A recombinant fowlpox disease virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. Arch Virol 1991; 120: 193-205.
19. Elbauer C et al. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase. Virology 1990; 179: 901-904.
20. Taylor J et al. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 1991; 9: 190-193.
21. Romero CH et al. Recombinant canarypox virus expressing the haemagglutinin protein gene of rinderpest virus: protection against rinderpest and lumpy skin disease viruses. Virology 1994; 204: 425-429.
22. Leveler C, Burny A, Meulemans G. Construction of pigenpox virus recombinant, expression of the Newcastle disease virus NDV fusion glycoprotein and protection of chickens against NDV challenge. Arch Virol 1991; 120. 193-205.
23. Cadoz M et al. Immunization with canarypox virus expressing rabies glycoprotein. Lancet 1992; 339: 1429-1432.
24. Egan MA et al. Induction of human immunodeficiency virus type I (HTV-I)-specific cytotoxic T lymphocyte responses in seronegative adult by a non-replicating host-range-restricted canarypox vector ALVAC carrying the HIV-IMN env gene. J Infect Dis 1995; 171: 1623-1627.
25. Heermann K-H, Gerlich WH. Surface proteins of hepatitis B viruses. In: McLachlan A (ed). Molecular Biology of the Hepatitis B Virus. CRC Press: Boca Raton, FL, 1991, pp 109-144.
26. Cheng K-C, Smith GL, Moss B. Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol 1986; 60: 337-344.
27. Watanabe K el al. Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen. Vaccine 1989; 7: 53-59.
28. Lubek MD et al. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci USA 1989; 86: 6763-6767.
29. Ballay A et al. In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses. EMBO J 1985; 4: 3861-3865.
30. Morin JE et al. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters. Proc Natl Acad Sci USA 1987; 84: 4626-4630.
31. Raney AK, McLachlan A. The biology of hepatitis B virus. In: McLachlan A (ed). Molecular Biology of the Hepatitis B Virus. CRC Press: Boca Raton, FL, 1991, pp 1-38.
32. Mortimer EA jr et al. Long-term follow-up of persons inadvertently inoculated with SV40 as neonates. New Engl J Med 1981; 305: 1517-1518.
33. Shah K, Nathanson N. Human exposure to SV40: review and comment. J. Epidemiol 1976; 103: 1-12.
34. Eckhart W. Polvmavirinae and their replication. In: Fields BN et al (eds). Virology. Raven Press: New York, 1990, pp 1593-1607.
35. Bryan TM, Raddel RR. SV40-induced immortalization of human cells. Crit Rev Oncogen 1994; 5: 331-357.
36. Butel JS, Jarvis DL. The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties. Biochem Biophys Acta 1986; 865: 171-195.
37. Law LW, Takemoto KK, Rogers MJ, Ting RC. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species. J Natl Cancer Inst 1977; 59: 1523-1526.
38. Cicurel L, Croce CM. Antibody response to simian virus 40 tumor antigen in nude mice reconstituted with T cells. J Immunol 1977; 119: 850-854.
39. Tevethia S. Characterization of hamster antibody reacting with papovavirus SV40 tumor antigen. J Immunol 1967; 98: 1257-1264
40. Crawford LV, Pirn DC, Lane DP. An immunochemical investigation of SV40 T-antigens. 2. Quantitation of antigens and antibody activities. Virology 1980; 100: 314-325.
41. Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975; 102: 331-340.
42. Stitt DT, Carroll RB, Melero JA, Mangel WF. Analysis of 84K, 55K and 48K proteins imrmmoprecipitable by SV40 T antibody from SV40-infected and -transformed cells by tryptic peptide mapping on cation-exchange columns. Virology 1981; 111: 283-288.
43. Atwood WJ, Norkin LC. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J Virol 1989; 63: 4474-4477.
44. Breau WC, Atwood WJ, Norkin LC. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol 1992; 66: 2037-2045.
45. Strayer DS et al. Titering replication-defective virus for use in gene transfer. BioTechniques 1997; 22: 447-150.
46. Hummeler K, Tomassini N, Sokol F. Morphological aspects of the uptake of simian virus 40 by permissive cells. J Virol 1970; 6: 87-93.
47. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, a Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989.
48. Lerner RA et al. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci USA 1981; 78: 3403-3407.